Tobramycin And Dexamethasone
Product Images NDC 68071-2772

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tobramycin And Dexamethasone (NDC 68071-2772). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticasl,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2772 2)

Label for Tobramycin 0.3% and Dexamethasone 0.1% ophthalmic suspension, 2.5 mL, manufactured by Rafarm S.A., Attiki, Greece and packaged by NuCare Pharmaceuticals, Inc., Orange, CA. The label includes dosage instructions, active ingredient concentrations, storage conditions, and regulatory information including NDC 68071-2772.*

FDA Label Image

Tobramycin (Image 01)

Chemical structure diagram of the active ingredient in TOBRAMYCIN AND DEXAMETHASONE, showing molecular components including amino, hydroxyl, and ether groups arranged in a complex ring formation.*

FDA Label Image

Dexamethasone (Image 02)

Chemical structure of the active ingredient dexamethasone shown as a detailed molecular diagram indicating atoms and bonds typical of corticosteroid compounds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.